{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:32:32Z","timestamp":1780918352717,"version":"3.54.1"},"reference-count":44,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The Prostate"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Inactivating missense mutations in the tumor suppressor gene speckle\u2010type pox virus and zinc finger protein\n                      <jats:italic>(SPOP)<\/jats:italic>\n                      occur in 5%\u201315% of men with prostate cancer (PC).\n                      <jats:italic>SPOP<\/jats:italic>\n                      mutations increase androgen receptor\u2010mediated transcription and enhance sensitivity to hormonal therapies. Here we describe the clinical characteristics, outcomes, and mutational patterns in Veterans with SPOP\u2010mutated PC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This retrospective cohort was defined as men diagnosed with PC between January 1, 2000 and September, 30 2024 in the Veterans Affairs health care system with an\n                      <jats:italic>SPOP<\/jats:italic>\n                      mutation identified on genomic testing. The primary and secondary outcomes were overall survival (OS) from date of metastasis and metastatic castration\u2010resistant PC (mCRPC) to death or censoring on December 31, 2024, and adjusted for left truncation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 984 Veterans with SPOP\u2010mutated PC, most Veterans (78.4%) received at least one androgen receptor pathway inhibitor (ARPI) and 20.2% received docetaxel. Median OS from date of metastasis (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009898) was 42.0 mo (95% CI: 38.1\u201348.2). Median OS from mCRPC diagnosis (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009425) was 23.5 mo (95% CI: 19.4\u201329.5). We also identified a subgroup of 114 patients with de novo metastatic hormone\u2010sensitive PC (mHSPC), 96 who received androgen deprivation therapy (ADT)\u2009+\u2009ARPI (doublet) and 18 who received ADT\u2009+\u2009ARPI\u2009+\u2009docetaxel (triplet) as initial therapy. Median OS from diagnosis to death was 48.3 mo (CI not estimable) in the doublet subgroup and not estimable in the triplet subgroup. The most common co\u2010occurring genetic alterations with\n                      <jats:italic>SPOP<\/jats:italic>\n                      in de novo mHSPC were\n                      <jats:italic>APC<\/jats:italic>\n                      (21.9%; 25\/114),\n                      <jats:italic>TP53<\/jats:italic>\n                      (18.4%; 21\/114), and\n                      <jats:italic>PTEN<\/jats:italic>\n                      (8.3%; 8\/114).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This is the largest cohort of men with\n                      <jats:italic>SPOP<\/jats:italic>\n                      mutations, including those with de novo mHSPC treated with an ARPI, reported to date. Further prospective study of SPOP\u2010mutated PC may help guide which patients with de novo mHSPC may either benefit from or can forego the addition of chemotherapy.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/pros.70161","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T19:09:42Z","timestamp":1773947382000},"page":"920-928","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["<i>SPOP<\/i>\n                    Mutations in Veterans With Prostate Cancer and Outcomes With Doublet and Triplet Therapy in De Novo Metastatic Hormone Sensitive Prostate Cancer"],"prefix":"10.1002","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1311-5416","authenticated-orcid":false,"given":"Joseph J.","family":"Park","sequence":"first","affiliation":[{"name":"Medical Oncology and Duke Cancer Institute, Duke University Durham North Carolina USA"},{"name":"Durham Veterans Affairs Medical Center Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin\u2010Lin","family":"Tseng","sequence":"additional","affiliation":[{"name":"Department of Veterans Affairs National Oncology Program Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Giagtzis","sequence":"additional","affiliation":[{"name":"Durham Veterans Affairs Medical Center Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Kelley","sequence":"additional","affiliation":[{"name":"Medical Oncology and Duke Cancer Institute, Duke University Durham North Carolina USA"},{"name":"Durham Veterans Affairs Medical Center Durham North Carolina USA"},{"name":"Department of Veterans Affairs National Oncology Program Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda L.","family":"Bitting","sequence":"additional","affiliation":[{"name":"Medical Oncology and Duke Cancer Institute, Duke University Durham North Carolina USA"},{"name":"Durham Veterans Affairs Medical Center Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.7205\/MILMED-D-16-00371"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2279"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2024.04.011"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1117679"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/PO.23.00088"},{"key":"e_1_2_9_8_1","first-page":"704","article-title":"SPOP and Cancer: A Systematic Review","volume":"10","author":"Clark A.","year":"2020","journal-title":"American Journal of Cancer Research"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1304502110"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1250255"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.24269"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.24481"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.01.013"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.02.004"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-0476"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109665"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.06.033"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-2228"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/PO-25-00590"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0937"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00323"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/CCI.21.00071"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.5153"},{"key":"e_1_2_9_24_1","doi-asserted-by":"crossref","unstructured":"J. P.KleinandM. L.Moeschberger: Survival Analysis: Techniques for Censored And Truncated Data (ed 2nd). New York Springer 2003.","DOI":"10.1007\/b97377"},{"key":"e_1_2_9_25_1","unstructured":"A. J.Foreman G. P.Lai andD. P.Miller: Surviving Left Truncation Using PROC PHREG Proceedings of the Western Users of SAS Software (WUSS). San Francisco CA ICON Clinical Research 2008."},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btz631"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(96)00075-X"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20820-x"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.9119"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-02608"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2025.0052"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.0228"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-023-00725-8"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2026.102502"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1704174"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00799"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903835"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903307"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-01798"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2119115"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00367-1"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.9433"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2024.102226"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2018.9"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-021-00430-4"}],"container-title":["The Prostate"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pros.70161","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/pros.70161","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pros.70161","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T13:50:08Z","timestamp":1777729808000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pros.70161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1002\/pros.70161"],"URL":"https:\/\/doi.org\/10.1002\/pros.70161","archive":["Portico"],"relation":{},"ISSN":["0270-4137","1097-0045"],"issn-type":[{"value":"0270-4137","type":"print"},{"value":"1097-0045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"2025-09-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}